The Scientist Creative Services Team | Aug 4, 2020
Erik Steinfelder and Bogi Eliasen will examine the importance of biobanking in precision medicine, from early-stage research to diagnostics and treatments.
The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.
Eric Topol,
founder and director of Scripps Research
Translational Institute and Reading
Frames author, discusses the future of
the doctor-patient bond in an era of
artificial intelligence–driven medicine.
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.